Position in PAHC
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$344,081
-$467,364 QoQ
Shares Held
10,958
-71.2% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#108
of 206 holders
Holding Since
Dec 2024
3 quarters on record
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Summit Global Investments holds $8,262,843 across 6 Drug Manufacturers - Specialty & Generic names. PAHC ranks #4 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
29,424 | $4,959,120 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
89,173 | $1,429,443 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,863 | $1,009,429 | |
| 4 | PAHC |
Phibro Animal Health Corp
This page
|
10,958 | $344,081 | |
| 5 | ALKS |
Alkermes plc.
|
6,001 | $314,452 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
4,436 | $206,318 |
All Filings in PAHC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $344,081 | 10,958 | Shares | Sole | 2026-08-03 | |
| 2025-03-31 | $811,445 | 37,989 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $570,801 | 27,181 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||